A CD24‐p53 axis contributes to African American prostate cancer disparities-Reference-Cited by-同舟云学术

A CD24‐p53 axis contributes to African American prostate cancer disparities

Published:2020-03-13 Issue:8 Volume:80 Page:609-618
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Liu Wei¹,Zhang Yue¹,Wei Shi²,Bae Sejong³,Yang Wei‐Hsiung⁴,Smith Gary J.⁵,Mohler James L.⁵,Fontham Elizabeth T. H.⁶,Bensen Jeannette T.⁷,Sonpavde Guru P.⁸,Chen Guo‐Yun⁹,Liu Runhua¹,Wang Lizhong¹^ORCID

Affiliation:

1. Department of Genetics and O'Neal Comprehensive Cancer CenterUniversity of Alabama at BirminghamBirmingham Alabama

2. Department of PathologyUniversity of Alabama at BirminghamBirmingham Alabama

3. Division of Preventive MedicineUniversity of Alabama at BirminghamBirmingham Alabama

4. Department of Biomedical SciencesMercer UniversitySavannah Georgia

5. Department of UrologyRoswell Park Comprehensive Cancer CenterBuffalo New York

6. School of Public HealthLouisiana State University Health Sciences CenterNew Orleans Louisiana

7. Lineberger Comprehensive Cancer Center and Gillings School of Global Public HealthUniversity of North Carolina at Chapel HillChapel Hill North Carolina

8. Dana‐Farber Cancer InstituteBoston Massachusetts

9. Department of PediatricsUniversity of Tennessee Health Science CenterMemphis Tennessee

Funder

U.S. National Cancer Institute

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23973

Reference51 articles.

1. CD24 overexpression in cancer development and progression: a meta‐analysis;Lee JH;Oncol Rep,2009